StoneX Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

StoneX Group’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,913	Closed	-$6.05K	–	761
2022 Q4	$6.05K	Buy	+13,913	New	+$4.52K	﹤0.01%	480

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

StoneX Group's SIOX Position: Q1 2023 in Review

StoneX Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 13,913 shares — an estimated $6.05K sold.

StoneX Group first reported a position in SIOX in Q4 2022 and held it in 1 quarter. The position peaked at $6.05K in Q4 2022. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

StoneX Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 13,913 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $6.05K.
StoneX Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2022 and held it in 1 quarter.
StoneX Group's Sio Gene Therapies Inc. Common Stock position peaked at $6.05K in Q4 2022.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.